Showing results (51-60 of 375) with videos related to
Sort By:
Pageof 38
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 27, 2021
Surgical Feasibility, Determinants, and Overall Efficacy of Neoadjuvant <sup>177</sup>Lu-DOTATATE PRRT for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine TumorsRahul V Parghane, Manish Bhandare, Vikram Chaudhari, et al.Nuclear Medicine Communications|July 8, 2024
Internal dosimetry and biodistribution of indigenously prepared 177 Lu-DOTA-rituximab in lymphoma and other hematological malignancies treated with rituximabYeshwanth Edamadaka, Rahul V Parghane, Sudeep Sahu, et al.Clinical Nuclear Medicine|February 13, 2024
Clinical Internal Dosimetry and Biodistribution of 177 Lu-DOTA-Trastuzumab in HER2-Positive Metastatic and Locally Advanced Breast CarcinomaYoga S Narwadkar, Rahul V Parghane, Sudeep Sahu, et al.Discovery Medicine|January 31, 2012
The scope and potentials of functional radionuclide imaging towards advancing personalized medicine in oncology: emphasis on PET-CTSandip BasuNature Reviews. Clinical Oncology|August 12, 2010
Personalized versus evidence-based medicine with PET-based imagingSandip BasuJournal of Nuclear Medicine Technology|December 8, 2021
Discordance Between Histopathologic Grading and Dual-Tracer PET/CT Findings in Metastatic NETs and Outcome of <sup>177</sup>Lu-DOTATATE PRRT: Does In Vivo Molecular PET Perform Better from the Viewpoint of Prediction of Tumor Biology?Aadil Adnan, Sandip BasuHellenic Journal of Nuclear Medicine|November 17, 2011
A pregnant woman with metastatic papillary thyroid carcinoma and paraplegia: Multiple considerations involved in the managementSandip Basu, Purushottam KandJournal of Nuclear Medicine Technology|May 3, 2020
Combined <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy and Platinum-Based Chemotherapy in Recurrent, Metastatic Sinonasal Neuroendocrine Carcinoma: A Promising Therapeutic OptionAadil Adnan, Sandip BasuWorld Journal of Nuclear Medicine|February 21, 2017
Metabolic Bone Disease in the Context of Metastatic Neuroendocrine Tumor: Differentiation from Skeletal Metastasis, the Molecular PET-CT Imaging Features, and Exploring the Possible Etiopathologies Including Parathyroid Adenoma (MEN1) and Paraneoplastic Humoral Hypercalcemia of Malignancy Due to PTHrP HypersecretionRohit Ranade, Sandip BasuWorld Journal of Radiology|April 30, 2014
Psoas muscle metastasis from cervical carcinoma: Correlation and comparison of diagnostic features on FDG-PET/CT and diffusion-weighted MRISandip Basu, Abhishek MahajanPageof 38